Sign in
QNTM Stock Price, Chart, Stats & News
Quantum BioPharma Ltd.
Save
Quantum BioPharma Ltd. (QNTM) does not currently pay a dividend.
25.08M
Market cap
–
Current P/E
–
Forward P/E
QNTM chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -235.37% |
ROE | -418.54% |
D/E | 0.27x |
Interest coverage ratio | -20.03x |
QNTM valuation
P/E | – |
P/S | – |
P/B | 2.68x |
P/CF | -2.25x |
P/FCF | -2.38x |
P/OCF | -2.25x |
PEG | -0.03x |
EV multiple | -0.80x |
About
Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development. Its operations are divided into two main divisions: its core biopharmaceutical activities and strategic investment holdings.
Similar securities
Based on sector and market capitalization
Report issue